1. Oxidative and inflammatory pathways in Parkinson’s disease / R. L. Miller [et al.] // Neurochemical Research. - 2008. - Vol. 34, N 1. - P. 55-65.
2. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson’s disease / E. Sofic [et al.] // Neuroscience Letters. - 1992. - Vol. 142, N 2. - P. 128-130.
3. Gu, F. Glutathione redox imbalance in brain disorders / F. Gu, V. Chauhan, A. Chauhan // Current Opinion in Clinical Nutrition and Metabolic Care. - 2015. - Vol. 18, N 1. - P. 89-95.
4. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation / J. Mieyal [et al.] // Antioxidants and redox signaling. - 2008. - Vol. 10, N 11. - P. 1941-1988.
5. Aoyama, K. Impaired glutathione synthesis in neurodegeneration / K. Aoyama, T. Nakaki // Intern. J. of Molecular Sciences. - 2013. - Vol. 14, N 10. - P. 21021-21044.
6. Thiol redox homeostasis in neurodegenerative disease / G. J. McBean [et al.] // Redox Biology. - 2015. - Vol. 5. - P. 186-194.
7. Johnson, W. M. Dysregulation of glutathione homeostasis in neurodegenerative diseases / W. M. Johnson, A. L. Wilson-Delfosse, J. J. Mieyal // Nutrients. - 2012. - Vol. 4, N 12. - P. 1399-1440.
8. Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson’s disease / J. L. Ridet [et al.] // Neurobiology of Disease. - 2006. - Vol. 21, N 1. - P. 29-34.
9. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson’s disease / K. Trinh [et al.] // J. of Neuroscience. - 2008. - Vol. 28, N 2. - P. 465-472.
10. Influence of glycyl-proline on the changes of the neuroactive amino acid metabolism and oxidative stress parameters in the rat brain in experimental Parkinson’s model / N. Bashun [et al.] // German Science. Herald. - 2017. - N 1. - P. 13-18.
11. Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction / J. H. Kim [et al.] // Neuroscience. - 2011. - Vol. 172. - P. 379-386.
12. Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals / Y. Wu [et al.] // Oncogene. - 2006. - Vol. 25, N 42. - P. 5787-5800.
13. Bhattacharya, P. Protective role for ovarian glutathione S-transferase isoform during 7,12-dimethylbenz[a]anthracene-induced ovotoxicity / P. Bhattacharya, A. F. Keating // Toxicology and Appl. Pharmacology. - 2012. - Vol. 260, N 2. - P. 201-208.
14. The xc − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine / J. Guan J. [et al.] // Cancer Chemother Pharmacology. - 2009. - Vol. 64, N 3. - P. 463-472.
15. Are glutathione S transferases involved in DNA damage signalling? Interactions with DNA damage and repair revealed from molecular epidemiology studies / M. Dusinska [et al.] // Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. - 2012. - Vol. 736, N 1-2. - P. 130-137.
16. Glutathione depletion and overproduction both initiate degeneration of nigral dopaminergic neurons / M. Garrido [et al.] // Acta Neuropathologica. - 2011. - Vol. 121, N 4. - P. 475-485.
17. Sabens, E. A. Levodopa deactivates enzymes that regulate thiol-disulfide homeostasis and promotes neuronal cell death: Implications for therapy of Parkinson’s disease / E. A. Sabens, A. M. Distler, J. J. Mieyal // Biochemistry. - 2010. - Vol. 49, N 12. - P. 2715-2724.
18. Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death / L. A. Volpicelli-Daley [et al.] // Neuron. - 2011. - Vol. 72, N 1. - P. 57-71.
19. Oxidized glutathione stimulated the amyloid formation of α-synuclein / S. R. Paik [et al.] // FEBS Letters. - 2003. - Vol. 537, N 1-3. - P. 63-67.
20. Differential effects of Parkinson’s disease-associated mutations on stability and folding of DJ-1 / K. Görner [et al.] // J. of Biol. Chemistry. - 2003. - Vol. 279, N 8. - P. 6943-6951.
21. DJ-1 loss by glutaredoxin but not glutathione depletion triggers Daxx translocation and cell death / U. Saeed [et al.] // Antioxidants and Redox Signaling. - 2010. - Vol. 13, N 2. - P. 127-144.
22. Chung, K. K. K. S-nitrosylation in Parkinson’s disease and related neurodegenerative disorders / K. K. Chung, V. L. Dawson, T. M. Dawson // Methods Enzymology. - 2005. - Vol. 396. - P. 139-150.
23. Bernhardi von, R. Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms / R. von Bernhardi, J. Eugenin // Antioxidants and Redox Signaling. - 2012. - Vol. 16, N 9. - P. 974-1031.
24. Jones, D. P. Radical-free biology of oxidative stress / D. P. Jones // Amer. J. of Physiology - Cell Physiology. - 2008. - Vol. 295, N 4. - P. C849-C868.
25. Physiological and pharmacological significance of glutathione-conjugate transport / Y. C. Awasthi [et al.] // J. of Toxicology and Environmental Health, Part B. - 2009. - Vol. 12, N 7. - P. 540-551.
26. Oxidative stress in neurodegenerative diseases: Mechanisms and therapeutic perspectives / A. Melo [et al.] // Oxidative Medicine and Cellular Longevity. - 2011. - Vol. 2011. - 14 p.
27. Kil, I. S. Regulation of mitochondrial NADP+-dependent isocitrate dehydrogenase activity by glutathionylation / I. S. Kil, J. W. Park // J. of Biol. Chemistry. - 2005. - Vol. 280, N 11. - P. 10846-10854.
28. Jung, K. H. Suppression of mitochondrial NADP(+)-dependent isocitrate dehydrogenase activity enhances curcumininduced apoptosis in HCT116 cells / K. H. Jung, J. W. Park // Free Radical Research. - 2011. - Vol. 45, N 4. - P. 431-438.
29. Attenuated mitochondrial NADP+-dependent isocitrate dehydrogenase activity enhances EGCG-induced apoptosis / I. S. Kil [et al.] // Biochimie. - 2011. - Vol. 93, N 10. - P. 1808-1815.
30. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson’s disease / W. M. Johnson [et al.] // Human Molecular Genetics. - 2015. - Vol. 24, N 5. - P. 1322-1335.
31. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson’s disease / J. Fang [et al.] // Proc. of the Nat. Acad. of Sciences. - 2007. - Vol. 104, N 47. - P. 18742-18747.
32. Molecular mechanisms and clinical implications of reversible protein S-glutathionylation / J. J. Mieyal [et al.] // Antioxidants and Redox Signaling. - 2008. - Vol. 10, N 11. - P. 1941-1988.
33. An ASK1-p38 signalling pathway mediates hydrogen peroxide-induced toxicity in NG108-15 neuronal cells / K. Nomura [et al.] // Neuroscience Letters. - 2013. - Vol. 549. - P. 163-167.
34. Drechsel, D. A. Respiration-dependent H2 O2 removal in brain mitochondria via the thioredoxin/peroxiredoxin system / D. A. Drechsel, M. Patel // J. of Biol. Chemistry. - 2010. - Vol. 285, N 36. - P. 27850-27858.
35. Lopert, P. Thioredoxin reductase deficiency potentiates oxidative stress, mitochondrial dysfunction and cell death in dopaminergic cells / P. Lopert, B. J. Day, M. Patel // PLoS One. - 2012. - Vol. 7, N 11. - Р. e50683.
36. Lopert, P. Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system / P. Lopert, M. Patel // J. of Biol. Chemistry. - 2014. - Vol. 289, N 22. - P. 15611-15620.
37. Gallogly, M. M. Mechanistic and kinetic details of catalysis of thiol-disulfide exchange by glutaredoxins and potential mechanisms of regulation / M. M. Gallogly, D. W. Starke, J. J. Mieyal // Antioxidants and Redox Signaling. - 2009. - Vol. 11, N 5. - P. 1059-1081.
38. Kenchappa, R. S. Glutaredoxin is essential for maintenance of brain mitochondrial complex I: studies with MPTP / R. S. Kenchappa, V. Ravindranath // FASEB J. - 2003. - Vol. 17, N 6. - P. 717-719.
39. Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity / L. Diwakar [et al.] // Neurochemistry Intern. - 2007. - Vol. 51, N 1. - P. 37-46.
40. A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial and cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson’s disease / D. W. Lee [et al.] // Antioxidants and Redox Signaling. - 2009. - Vol. 11, N 9. - P. 2083-2094.
41. Constitutive expression and functional characterization of mitochondrial glutaredoxin (Grx2) in mouse and human brain / S. Karunakaran [et al.] // Brain Resesrch. - 2007. - Vol. 1185. - P. 8-17.
42. Liedhegner, E. A. S. Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: Implications for the treatment of Parkinson’s disease / E. A. S. Liedhegner, K. M. Steller, J. J. Mieyal // Chem. Research in Toxicology. - 2011. - Vol. 24, N 10. - P. 1644-1652.
43. Knockdown of cytosolic glutaredoxin 1 leads to loss of mitochondrial membrane potential: implication in neurodegenerative diseases / U. Saeed [et al.] // PLoS One. - 2008. - Vol. 3, N 6. - P. e2459.
44. DJ-1 loss by glutaredoxin but not glutathione depletion triggers DAXX translocation and cell death / U. Saeed [et al.] // Antioxidants and Redox Signaling. - 2010. - Vol. 13, N 2. - P. 127-144.
45. Lopert, P. Brain mitochondria from DJ-1 knockout mice show increased respiration-dependent hydrogen peroxide consumption / P. Lopert, M. Patel // Redox Biology. - 2014. - Vol. 2. - P. 667-672.
46. Sabens Liedhegner, E. A. Mechanisms of altered redox regulation in neurodegenerative diseases - focus on S-glutathionylation / E. A. Sabens Liedhegner, X.-H. Gao, J. J. Mieyal // Antioxidants and Redox Signaling. - 2012. - Vol. 16, N 6. - P. 543-566.
47. Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection / H. Masutani [et al.] // Molecular Neurobiology. - 2004. - Vol. 29, N 3. - P. 229-242.
48. In vivo redox state of human thioredoxin and redox shift by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) / J. Ungerstedt [et al.] // Free Radical Biology and Medicine. - 2012. - Vol. 53, N 11. - P. 2002-2007.
49. Holmgren, A. Thioredoxin and thioredoxin reductase: current research with special reference to human disease / A. Holmgren, J. Lu // Biochem. and Biophys. Research Communications. - 2010. - Vol. 396, N 1. - P. 120-124.
50. Hashemy, S. I. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues / S. I. Hashemy, A. Holmgren // J. of Biol. Chemistry. - 2008. - Vol. 283, N 32. - P. 21890-21898.
51. Holmgren, A. Thioredoxin / A. Holmgren // Annu. Rev. of Biochemistry. - 1985. - Vol. 54. - P. 237-271.
52. Lillig, C. H. Thioredoxin and related molecules: from biology to health and disease / C. H. Lillig, A. Holmgren // Antioxidants and Redox Signaling. - 2007. - Vol. 9, N 1. - P. 25-47.
53. Powis, G. Properties and biological activities of thioredoxins / G. Powis, W. R. Montfort // Annu. Rev. of Biophysics and Biomolecular Structure. - 2001. - Vol. 30, N 1. - P. 421-455.
54. DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex / J. Y. Im [et al.] // Neuroscience Research. - 2010. - Vol. 67, N 3. - P. 203-208.
55. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase / E. Andres-Mateos [et al.] // Proc. of the Nat. Acad. of Sciences. - 2007. - Vol. 104, N 37. - P. 14807-14812.
56. Redox Regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus / Y. Kabe [et al.] // Antioxidants and Redox Signaling. - 2005. - Vol. 7, N 3-4. - P. 395-403.
57. Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis / M. Niso-Santano [et al.] // Free Radical Biology and Medicine. - 2010. - Vol. 48, N 10. - P. 1370-1381.
58. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity / J. W. Zhu [et al.] // Biochimie. - 2012. - Vol. 94, N 3. - P. 617-627.
59. Paraquat activates the IRE1/ASK1/JNK cascade associated with apoptosis in human neuroblastoma SH-SY5Y cells / W. Yang [et al.] // Toxicology Letters. - 2009. - Vol. 191, N 2-3. - P. 203-210.
60. Downregulation of thioredoxin reductase 1 expression in the substantia nigra pars compacta of Parkinson’s disease mice / Z. Liu [et al.] // Neural Regeneration Research. - 2013. - Vol. 8, N 35. - P. 3275-3283.
61. The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease / X. S. Zeng [et al.] // Free Radical Biology and Medicine. - 2014. - Vol. 67. - P. 10-18.
62. Thioredoxin suppresses Parkin-associated endothelin receptor-like receptor-induced neurotoxicity and extends longevity in drosophila / Y. Umeda-Kameyama [et al.] // J. of Biol. Chemistry. - 2007. - Vol. 282, N 15. - P. 11180-11187.
63. Healthy ageing and depletion of intracellular glutathione influences T cell membrane thioredoxin-1 levels and cytokine secretion / R. B. Carilho Torrao [et al.] // Chemistry Central J. - 2013. - Vol. 7, N 1. - P. 150.
64. Hattori, F. Peroxiredoxins in the central nervous system / F. Hattori, S. Oikawa // Peroxiredoxin Systems / ed. : L. Flohé, J. R. Harris. - Dordrecht, 2007. - P. 357-374. - (Subcellular Biochemistry ; vol. 44).
65. Nitration transforms a sensitive peroxiredoxin 2 into a more active and robust peroxidase / L. M. Randall [et al.] // J. of Biol. Chemistry. - 2014. - Vol. 289, N 22. - P. 15536-15543.
66. Protective effects of peroxiredoxin 6 overexpression on amyloid beta-induced apoptosis in PC12 cells / I. K. Kim [et al.] // Free Radical Research. - 2013. - Vol. 47, N 10. - P. 836-846.
67. Acceleration of the development of Alzheimer’s disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice / H. M. Yun [et al.] // Molecular Neurobiology. - 2013. - Vol. 48, N 3. - P. 941-951.
68. Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease / Y. M. Lee [et al.] // J. of Biol. Chemistry. - 2008. - Vol. 283, N 15. - P. 9986-9998.
69. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death / D. C. Angeles [et al.] // Human Mutation. - 2011. - Vol. 32, N 12. - P. 1390-1397.
70. D’Autreaux, B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis / B. D’Autréaux, M. Toledano // Nature Rev. Molecular Cell Biology. - 2007. - Vol. 8, N 10. - P. 813-824.